HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

6.440

+0.0701.10%

Volume:313.07M

Turnover:2.03B

Market Cap:120.82B

PE:30.79

High:6.720

Open:6.720

Low:6.370

Close:6.370

Loading ...

Overview Company News Filings

Sino Biopharmaceutical Limited's TDI01 Suspension Recognized in Breakthrough Therapy Designation Process by CDE for Chronic Graft-Versus-Host Disease Treatment

BRIEF-Sino Biopharmaceutical Says New Indication Of TDI01 Suspension ("Rock2 Inhibitor") Included In Breakthrough Therapy Designation Process By CDE

Sino Biopharmaceutical - New Indication of Tdi01 Suspension ("Rock2 Inhibitor") Included in Breakthrough Therapy Designation Process by Cde

THOMSON REUTERS

Sino Biopharmaceutical Limited Secures FDA Approval for TQB3002 Clinical Trials, Showcasing Innovation-Driven Progress

Sino Biopharmaceutical Limited Conducted Annual General Meeting

BRIEF-Sino Biopharmaceutical Updates On Phase III Registrational Clinical Study Of TQB2868 Injection

Sino Biopharmaceutical - Cde Approval to Initiate Phase Iii Registrational Clinical Study of Tqb2868 Injection Pd-1/Tgf- Bi-Functional Fusion Protein

THOMSON REUTERS

Sino Biopharmaceutical Limited's TQC3721 Inhalation Suspension Receives Phase III Clinical Study Approval from CDE for COPD Treatment

Sino Biopharmaceutical - Tqc3721 Inhalation Suspension "Pde3/4 Inhibitor" Approved by Center for Drug Evaluation by Nmpa China

THOMSON REUTERS

Sino Biopharm Presents Lung Cancer Drug Trial Data at US Oncology Conference

MT Newswires Live

Sino Biopharm Presents Lung Cancer Study Data at American Oncology Conference

MT Newswires Live

Sino Biopharmaceutical Limited Presents Promising Phase II Study Results for TQB2868 in Treating Metastatic Pancreatic Cancer at 2025 ASCO Meeting

Sino Biopharm Presents Cancer Drug Data at Oncology Conference

MT Newswires Live

Sino Biopharmaceutical Presents Lung Cancer Drug Trial Data at US Oncology Society Meeting

MT Newswires Live

Sino Biopharmaceutical Gets FDA Nod to Market Cancer Drug

MT Newswires Live

Sino Biopharmaceutical - Approval for Marketing of Penpulimab Injection by US FDA

THOMSON REUTERS

Sino Biopharmaceutical Gets China Nod for Hematologic Tumor Drug Trial

MT Newswires Live

BRIEF-Sino Biopharmaceutical Says Tqb3019 (Btk Protac) Approved For Clinical Trial By NMPA

Sino Biopharmaceutical - Tqb3019 (Btk Protac) Approved for Clinical Trial by Nmpa

THOMSON REUTERS

Sino Biopharmaceutical's Anti-Tumor Drug Gets Implied Approval from China

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01177/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01177","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01177\",,,,,undefined,":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"SINO BIOPHARM","latestPrice":6.44,"timestamp":1752653287013,"preClose":6.37,"halted":0,"volume":313068441,"delay":0,"floatShares":18761000000,"shares":18761000000,"eps":0.20917963656629723,"marketStatus":"Not Yet Opened","change":0.07,"latestTime":"07-16 16:08:07","open":6.72,"high":6.72,"low":6.37,"amount":2029236705,"amplitude":0.054945,"askPrice":6.44,"askSize":271000,"bidPrice":6.43,"bidSize":326000,"shortable":3,"etf":0,"ttmEps":0.20911512725674278,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1752715800000},"marketStatusCode":0,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":6.37,"dividendRate":0.01087,"openAndCloseTimeList":[[1752629400000,1752638400000],[1752642000000,1752652800000]],"volumeRatio":1.5948338453571256,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.6063,"impliedVolPercentile":0.9756},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01177\",,,,,undefined,":{"symbol":"01177","floatShares":18761000000,"roa":"5.62%","roe":"11.82%","lyrEps":0.20918,"volumeRatio":1.5948338453571256,"shares":18761000000,"dividePrice":0.07,"high":6.72,"amplitude":0.054945,"preClose":6.37,"low":6.37,"week52Low":2.651,"pbRate":"3.46","psRate":"3.83","week52High":6.72,"institutionHeld":0,"latestPrice":6.44,"committee":0.092127,"eps":0.20917963656629723,"divideRate":0.01087,"volume":313068441,"delay":0,"ttmEps":0.20911512725674278,"open":6.72,"prevYearClose":3.177,"prevWeekClose":5.93,"prevMonthClose":5.26,"prevQuarterClose":5.26,"fiveDayClose":5.91,"twentyDayClose":5,"sixtyDayClose":3.584},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01177\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543675715","title":"Sino Biopharmaceutical Limited's TDI01 Suspension Recognized in Breakthrough Therapy Designation Process by CDE for Chronic Graft-Versus-Host Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2543675715","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543675715?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:15","pubTimestamp":1750068924,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited's TDI01 Suspension Recognized in Breakthrough Therapy Designation Process by CDE for Chronic Graft-Versus-Host Disease Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on June 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL5v9DWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","IE00BZ08YR35.GBP","BK1589","BK1515","01177","BK1191","IE00BZ08YT58.USD","IE00BZ08YS42.EUR"],"gpt_icon":1},{"id":"2543367579","title":"BRIEF-Sino Biopharmaceutical Says New Indication Of TDI01 Suspension (\"Rock2 Inhibitor\") Included In Breakthrough Therapy Designation Process By CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=2543367579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543367579?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:11","pubTimestamp":1750068708,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Says New Indication Of TDI01 Suspension  Included In Breakthrough Therapy Designation Process By CDEJune 16  - Sino Biopharmaceutical Ltd 1177.HK:NEW INDICATION OF TDI01 SUSPENSION  INCLUDED IN BREAKTHROUGH THERAPY DESIGNATION PROCESS BY CDEFurther company coverage: 1177.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SG0LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1589","BK1191","01177","BK1521","IE00BZ08YR35.GBP","BK1515"],"gpt_icon":0},{"id":"2543675491","title":"Sino Biopharmaceutical -  New Indication of Tdi01 Suspension (\"Rock2 Inhibitor\") Included in Breakthrough Therapy Designation Process by Cde","url":"https://stock-news.laohu8.com/highlight/detail?id=2543675491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543675491?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:10","pubTimestamp":1750068611,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SG0LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YR35.GBP","01177","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1589","BK1191","BK1521"],"gpt_icon":0},{"id":"2543528646","title":"Sino Biopharmaceutical Limited Secures FDA Approval for TQB3002 Clinical Trials, Showcasing Innovation-Driven Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2543528646","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543528646?lang=en_us&edition=fundamental","pubTime":"2025-06-13 06:11","pubTimestamp":1749766290,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited has announced significant progress in its innovation-driven development strategy, as highlighted in a recent voluntary announcement. The company's application for clinical trials of TQB6411, an EGFR/cMet Bispecific ADC, has been accepted by the Center for Drug Evaluation  of the National Medical Products Administration of China. Additionally, TQB2922, an EGFR/cMet Bispecific Antibody, has entered Phase I trials, while TQB3002, a Fourth-Generation EGFR Inhibitor, received approval for clinical trials from the United States Food and Drug Administration  in November of the previous year. These advancements underscore the company's commitment to innovation and its ongoing efforts to enhance its pipeline of clinical-stage assets with First-In-Class and Best-In-Class potential.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL4QbwH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","IE00BZ08YT58.USD","BK1589","BK1515","BK1521","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1191"],"gpt_icon":0},{"id":"2542315952","title":"Sino Biopharmaceutical Limited Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542315952","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542315952?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:45","pubTimestamp":1749552308,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited held its Annual General Meeting on 10 June 2025. During the meeting, the proposal to receive and adopt the audited consolidated financial statements for the year ended 31 December 2024 was approved. Additionally, the proposal to approve the payment of a final dividend for the year ended 31 December 2024 was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on June 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDLH7tgL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK1191","BK1515","01177","BK1589","BK1521","IE00BZ08YS42.EUR","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2542313294","title":"BRIEF-Sino Biopharmaceutical Updates On Phase III Registrational Clinical Study Of TQB2868 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2542313294","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542313294?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:28","pubTimestamp":1749551300,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Updates On Phase III Registrational Clinical Study Of TQB2868 InjectionJune 10  - Sino Biopharmaceutical Ltd 1177.HK:CDE APPROVAL TO INITIATE PHASE III REGISTRATIONAL CLINICAL STUDY OF TQB2868 INJECTION PD-1/TGF- BI-FUNCTIONAL FUSION PROTEINFurther company coverage: 1177.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nFWN3SC0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1589","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1521","BK1515","01177"],"gpt_icon":0},{"id":"2542390955","title":"Sino Biopharmaceutical - Cde Approval to Initiate Phase Iii Registrational Clinical Study of Tqb2868 Injection Pd-1/Tgf- Bi-Functional Fusion Protein","url":"https://stock-news.laohu8.com/highlight/detail?id=2542390955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542390955?lang=en_us&edition=fundamental","pubTime":"2025-06-10 17:57","pubTimestamp":1749549473,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nFWN3SC0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01177","IE00BZ08YT58.USD","BK1589","BK1515","BK1521","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1191"],"gpt_icon":0},{"id":"2542338138","title":"Sino Biopharmaceutical Limited's TQC3721 Inhalation Suspension Receives Phase III Clinical Study Approval from CDE for COPD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338138","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542338138?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:41","pubTimestamp":1749469312,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited's TQC3721 Inhalation Suspension Receives Phase III Clinical Study Approval from CDE for COPD Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL4jQqDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1521","BK1589","BK1515","BK1191","01177","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2542882381","title":"Sino Biopharmaceutical - Tqc3721 Inhalation Suspension \"Pde3/4 Inhibitor\" Approved by Center for Drug Evaluation by Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2542882381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542882381?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:39","pubTimestamp":1749469155,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YR35.GBP","01177","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1589","BK1191","BK1521"],"gpt_icon":0},{"id":"2541446500","title":"Sino Biopharm Presents Lung Cancer Drug Trial Data at US Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2541446500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541446500?lang=en_us&edition=fundamental","pubTime":"2025-06-05 16:08","pubTimestamp":1749110917,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) presented the latest results of the phase III clinical study of its benmelstobart injection at the 2025 American Society of Clinical Oncology Annual Meeting, a Thursd","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1521","01177","BK1515","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1589","BK1191","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2540779995","title":"Sino Biopharm Presents Lung Cancer Study Data at American Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2540779995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540779995?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:59","pubTimestamp":1748951972,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  presented the latest results of the phase III clinical study for benmelstobart injection in combination with anlotinib hydrochloride capsules at the American Society of Clinical Oncology's annual meetingThe drug is being tested as first-line treatment for non-small cell lung cancer in comparison with the pembrolizumab injection.The study has achieved the primary study endpoint of progression-free survival, in which the median survival was prolonged by more than 6 months in the population with TPS ≥50%.There was also a 40% reduction in the risk of disease progression and death as compared with the arm of pembrolizumab.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YR35.GBP","BK1521","BK1191","01177","BK4107","AFG","IE00BZ08YT58.USD","BK1589","BK1515","BK4117","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2539250463","title":"Sino Biopharmaceutical Limited Presents Promising Phase II Study Results for TQB2868 in Treating Metastatic Pancreatic Cancer at 2025 ASCO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2539250463","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539250463?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:23","pubTimestamp":1748521386,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited Presents Promising Phase II Study Results for TQB2868 in Treating Metastatic Pancreatic Cancer at 2025 ASCO Meeting. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on May 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDLbJ1hqs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","01177","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1589","BK1191","BK1521"],"gpt_icon":0},{"id":"2538445804","title":"Sino Biopharm Presents Cancer Drug Data at Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2538445804","media":"MT Newswires Live","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538445804?lang=en_us&edition=fundamental","pubTime":"2025-05-28 15:13","pubTimestamp":1748416438,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  presented preliminary data from its first-in-human Phase I clinical study of cancer drug TQB2102 at the 2025 ASCO Annual Meeting, according to a Tuesday filing with the Hong Kong Exchange.The company reported encouraging results, with response rates of up to 70% in certain HER2-positive cancers, including breast and gastric cancers -- even among patients who had not responded to prior treatments.Side effects were described as manageable, with only a few cases of serious lung-related adverse events.TQB2102 is currently in Phase 3 trials and, if successful, could become the world's first approved bispecific HER2 antibody-drug conjugate , the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","IE00BZ08YR35.GBP","BK1521","ADC.AU","BK1191","01177","BK4231","ADC","IE00BZ08YT58.USD","BK1589","BK1515","BK4080","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2537135011","title":"Sino Biopharmaceutical Presents Lung Cancer Drug Trial Data at US Oncology Society Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2537135011","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537135011?lang=en_us&edition=fundamental","pubTime":"2025-05-23 19:50","pubTimestamp":1748001055,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  presented the latest results of a Benmelstobart injection study to treat advanced squamous non-small cell lung cancer at the 2025 American Society of Clinical Oncology  Annual Meeting, a Friday Hong Kong bourse filing said.The phase III clinical trial studies the use of the drug in combination with chemotherapy, followed by sequential combination with Anlotinib Hydrochloride capsules, versus the Tislelizumab injection in combination with chemotherapy.The trial shows that the drug in combination with the other therapies significantly prolonged median progression-free survival compared with Tislelizumab, reducing the risk of disease progression or death by 36% in the trial group.The overall safety of the trial group was also good.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","IE00BZ08YT58.USD","01177","BK1191","IE00BZ08YR35.GBP","BK1521","IE00BZ08YS42.EUR","BK1589"],"gpt_icon":0},{"id":"2530929187","title":"Sino Biopharmaceutical Gets FDA Nod to Market Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2530929187","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530929187?lang=en_us&edition=fundamental","pubTime":"2025-04-25 13:55","pubTimestamp":1745560557,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical's  co-developed penpulimab injection secured marketing approval from the US Food and Drug Administration, a Friday Hong Kong bourse filing said.The drug is indicated either in combination with cisplatin or carboplatin and gemcitabine, or as a single agent, to treat adults with recurrent or metastatic non-keratinizing nasopharyngeal carcinoma.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01177","BK1589","BK1515","BK1521","BK1191"],"gpt_icon":0},{"id":"2530947958","title":"Sino Biopharmaceutical - Approval for Marketing of Penpulimab Injection by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2530947958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530947958?lang=en_us&edition=fundamental","pubTime":"2025-04-25 12:17","pubTimestamp":1745554658,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R23K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01177","BK1515","BK1521","BK1191","BK1589"],"gpt_icon":0},{"id":"2526530013","title":"Sino Biopharmaceutical Gets China Nod for Hematologic Tumor Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2526530013","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526530013?lang=en_us&edition=fundamental","pubTime":"2025-04-10 17:56","pubTimestamp":1744278967,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  obtained clinical trial approval for its self-developed TQB3019  from China's National Medical Products Administration, a Wednesday filing with the Hong Kong bourse said.The drug is intended for use in the treatment of hematologic tumors, according to the biopharmaceutical firm.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1521","01177","BK1515","BK1589","BK1191"],"gpt_icon":0},{"id":"2526359258","title":"BRIEF-Sino Biopharmaceutical Says Tqb3019 (Btk Protac) Approved For Clinical Trial By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2526359258","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526359258?lang=en_us&edition=fundamental","pubTime":"2025-04-09 18:38","pubTimestamp":1744195128,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Says Tqb3019 (Btk Protac) Approved For Clinical Trial By NMPAApril 9 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK:TQB3019 (BTK PROTAC) APPROVED FOR CLINICAL TRIAL BY NMPAFurther company coverage: 1177.HK ((Reuter.Briefs@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QM2AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","BK1191","01177","BK1589","BK1515"],"gpt_icon":0},{"id":"2526356894","title":"Sino Biopharmaceutical -  Tqb3019 (Btk Protac) Approved for Clinical Trial by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2526356894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526356894?lang=en_us&edition=fundamental","pubTime":"2025-04-09 18:14","pubTimestamp":1744193676,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QM2AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01177","BK1515","BK1521","BK1191","BK1589"],"gpt_icon":0},{"id":"2524273305","title":"Sino Biopharmaceutical's Anti-Tumor Drug Gets Implied Approval from China","url":"https://stock-news.laohu8.com/highlight/detail?id=2524273305","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524273305?lang=en_us&edition=fundamental","pubTime":"2025-04-04 15:09","pubTimestamp":1743750574,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical's  TQB2101 anti-tumor obtained Chinese implied approval for clinical trials, according to a Thursday filing with the Hong Kong bourse.The drug showed anti-tumor activity in receptor tyrosine kinase-like orphan receptor-1-positive tumor models during preclinical studies, the filing said.ROR-1 is seen in lung, pancreatic, breast, colorectal, and ovarian cancers, the filing said.Separately, China's medical products administrator accepted Sino Biopharm's clinical trial application for its TQB6411 anti-lung cancer drugs.The drug targets the epidermal growth factor receptor and cell mesenchymal epithelial transition present as lung cancer driver genes, according to a separate Thursday filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01177","BK1589","BK1515","BK1521","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":82,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01177\",params:#limit:5,,,undefined,":[{"date":"2025-06-16","symbol":"01177","amount":0.04,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-17","defaultRemindTime":1750037400000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-10","payableDate":"2025-06-17","currency":"HKD","dateTimestamp":1750003200000,"payDate":"2025-07-10"},{"date":"2025-03-20","symbol":"01177","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742434200000,"name":null,"time":"Post Market","dateTimestamp":1742400000000,"actualEps":null},{"date":"2024-09-10","symbol":"01177","amount":0.03,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-09-11","defaultRemindTime":1725931800000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-04","payableDate":"2024-09-11","currency":"HKD","dateTimestamp":1725897600000,"payDate":"2024-10-04"},{"date":"2024-08-13","symbol":"01177","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723512600000,"name":null,"time":"","dateTimestamp":1723478400000,"actualEps":null},{"date":"2024-06-11","symbol":"01177","amount":0.03,"announcedDate":"2024-03-28","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-12","name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-12","currency":"HKD","dateTimestamp":1718035200000,"payDate":"2024-07-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01177\",market:\"HK\",,,undefined,":[{"executeDate":"2015-09-10","recordDate":"2015-09-11","paymentDate":"2015-09-25","value":0.015,"currency":"HKD"},{"executeDate":"2015-12-03","recordDate":"2015-12-04","paymentDate":"2015-12-18","value":0.01,"currency":"HKD"},{"executeDate":"2016-06-17","recordDate":"2016-06-20","paymentDate":"2016-07-06","value":0.015,"currency":"HKD"},{"executeDate":"2016-06-28","recordDate":"2016-06-29","paymentDate":"2016-07-13","value":0.015,"currency":"HKD"},{"executeDate":"2016-09-12","recordDate":"2016-09-13","paymentDate":"2016-09-29","value":0.015,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01177\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.65,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.65,"analysts":20,"updateTime":1742918400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01177\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01177","date":"2025-07-15","current":29.746194,"percent":0.773723,"low":4.081901,"twenty":8.758254,"median":20.194879,"eighty":32.084404,"high":66.468376,"avg":22.959983,"sd":15.817754,"marketCap":113925289213},"quantilePoints":[{"date":"2020-07-17","current":61.53984,"twenty":13.701963,"median":44.431183,"eighty":56.233641,"marketCap":189766014059},{"date":"2020-07-24","current":60.843107,"twenty":13.716603,"median":45.405377,"eighty":56.910966,"marketCap":186883199696},{"date":"2020-07-31","current":61.461695,"twenty":13.759986,"median":45.958823,"eighty":58.777439,"marketCap":189891379973},{"date":"2020-08-07","current":58.963955,"twenty":13.769121,"median":46.360295,"eighty":59.883242,"marketCap":182370929281},{"date":"2020-08-14","current":55.542111,"twenty":13.795226,"median":46.520262,"eighty":59.435529,"marketCap":172218320846},{"date":"2020-08-21","current":55.411971,"twenty":13.832409,"median":46.795246,"eighty":59.213993,"marketCap":172594343381},{"date":"2020-08-28","current":60.163247,"twenty":13.843189,"median":47.558626,"eighty":59.213993,"marketCap":173722410985},{"date":"2020-09-04","current":58.986741,"twenty":13.850757,"median":47.865151,"eighty":59.435529,"marketCap":170902241975},{"date":"2020-09-11","current":57.173399,"twenty":13.883621,"median":48.442377,"eighty":59.21855,"marketCap":165825937758},{"date":"2020-09-18","current":57.33064,"twenty":13.942776,"median":49.171229,"eighty":58.982184,"marketCap":167894061698},{"date":"2020-09-25","current":55.524771,"twenty":13.951913,"median":49.248862,"eighty":58.955787,"marketCap":161313667343},{"date":"2020-09-30","current":54.359485,"twenty":13.954627,"median":49.670791,"eighty":58.931282,"marketCap":158681509601},{"date":"2020-10-09","current":53.778431,"twenty":13.960541,"median":49.956226,"eighty":58.340413,"marketCap":159245543403},{"date":"2020-10-16","current":50.497525,"twenty":13.997021,"median":50.336386,"eighty":58.143055,"marketCap":149468957503},{"date":"2020-10-23","current":50.355948,"twenty":14.012019,"median":50.497525,"eighty":58.116139,"marketCap":149280946236},{"date":"2020-10-30","current":49.587245,"twenty":14.022766,"median":50.497525,"eighty":57.977657,"marketCap":147024811028},{"date":"2020-11-06","current":50.89449,"twenty":14.085895,"median":50.432692,"eighty":57.866732,"marketCap":152665149047},{"date":"2020-11-13","current":49.724519,"twenty":14.135565,"median":50.355948,"eighty":57.69443,"marketCap":149280946236},{"date":"2020-11-20","current":49.012194,"twenty":14.18623,"median":50.176763,"eighty":57.578882,"marketCap":148065189992},{"date":"2020-11-27","current":47.319039,"twenty":14.216673,"median":50.039264,"eighty":57.517846,"marketCap":142616090360},{"date":"2020-12-04","current":46.016259,"twenty":14.236727,"median":49.897365,"eighty":57.391022,"marketCap":125705091503},{"date":"2020-12-11","current":46.402423,"twenty":14.271192,"median":49.828846,"eighty":57.304037,"marketCap":126456691452},{"date":"2020-12-18","current":53.761713,"twenty":14.294685,"median":49.832685,"eighty":57.21856,"marketCap":146749890081},{"date":"2020-12-24","current":51.299504,"twenty":14.315124,"median":49.897365,"eighty":57.170065,"marketCap":140173390525},{"date":"2020-12-31","current":51.553444,"twenty":14.337629,"median":50.061376,"eighty":57.163601,"marketCap":140924990475},{"date":"2021-01-08","current":51.570185,"twenty":51.495824,"median":51.669892,"eighty":52.08865,"marketCap":142240290386},{"date":"2021-01-15","current":48.164183,"twenty":49.466567,"median":51.481419,"eighty":51.825064,"marketCap":132657391033},{"date":"2021-01-22","current":54.463456,"twenty":49.466567,"median":51.553444,"eighty":52.465676,"marketCap":149944189865},{"date":"2021-01-29","current":48.94011,"twenty":49.115564,"median":51.481419,"eighty":52.465676,"marketCap":135851690817},{"date":"2021-02-05","current":50.665081,"twenty":49.478407,"median":51.553444,"eighty":52.234143,"marketCap":139797590551},{"date":"2021-02-11","current":51.544559,"twenty":49.814781,"median":51.450982,"eighty":52.040567,"marketCap":142428190373},{"date":"2021-02-19","current":51.861937,"twenty":50.11446,"median":51.553444,"eighty":52.089065,"marketCap":143367690309},{"date":"2021-02-26","current":58.788258,"twenty":50.29451,"median":51.620038,"eighty":52.588108,"marketCap":162157689039},{"date":"2021-03-05","current":56.545782,"twenty":50.420098,"median":51.774136,"eighty":54.987533,"marketCap":155581189484},{"date":"2021-03-12","current":57.260655,"twenty":50.670382,"median":51.806517,"eighty":56.523353,"marketCap":157272289370},{"date":"2021-03-19","current":58.922145,"twenty":50.72578,"median":51.861937,"eighty":57.761618,"marketCap":161781889065},{"date":"2021-03-26","current":45.655381,"twenty":50.29451,"median":51.834875,"eighty":57.761618,"marketCap":150248149840},{"date":"2021-04-01","current":44.402146,"twenty":49.232534,"median":51.785727,"eighty":57.72338,"marketCap":145740705344},{"date":"2021-04-09","current":46.245526,"twenty":48.491535,"median":51.774136,"eighty":57.445745,"marketCap":152126251713},{"date":"2021-04-16","current":45.843578,"twenty":47.071442,"median":51.620038,"eighty":56.905893,"marketCap":151375010963},{"date":"2021-04-23","current":47.941821,"twenty":46.674186,"median":51.544559,"eighty":56.595223,"marketCap":158699608268},{"date":"2021-04-30","current":47.292985,"twenty":46.892133,"median":51.338718,"eighty":56.478494,"marketCap":157197126770},{"date":"2021-05-07","current":44.686819,"twenty":46.674186,"median":50.949156,"eighty":55.644586,"marketCap":149496909090},{"date":"2021-05-14","current":47.693245,"twenty":46.358223,"median":50.678334,"eighty":54.98161,"marketCap":159450849017},{"date":"2021-05-21","current":49.252593,"twenty":46.446515,"median":50.318638,"eighty":54.739526,"marketCap":164709534262},{"date":"2021-05-28","current":34.796197,"twenty":46.015,"median":49.739468,"eighty":54.493388,"marketCap":161516761078},{"date":"2021-06-04","current":34.961943,"twenty":45.626349,"median":49.242564,"eighty":54.023478,"marketCap":161516761078},{"date":"2021-06-11","current":33.744804,"twenty":45.33083,"median":48.556215,"eighty":53.234644,"marketCap":155882455459},{"date":"2021-06-18","current":31.684335,"twenty":44.686491,"median":48.197481,"eighty":52.95221,"marketCap":145177274782},{"date":"2021-06-25","current":31.663274,"twenty":43.967373,"median":48.122902,"eighty":52.588108,"marketCap":144989464595},{"date":"2021-07-02","current":30.69154,"twenty":35.796618,"median":47.817533,"eighty":52.557854,"marketCap":140294209913},{"date":"2021-07-09","current":28.583686,"twenty":35.31878,"median":47.514473,"eighty":52.379013,"marketCap":130528080173},{"date":"2021-07-16","current":29.160074,"twenty":34.796197,"median":47.414412,"eighty":52.137563,"marketCap":133157422795},{"date":"2021-07-23","current":28.751555,"twenty":33.744804,"median":47.292985,"eighty":51.895074,"marketCap":131279320922},{"date":"2021-07-30","current":27.039046,"twenty":31.787963,"median":47.023101,"eighty":51.861937,"marketCap":123874830618},{"date":"2021-08-06","current":28.500789,"twenty":31.650912,"median":46.804358,"eighty":51.849781,"marketCap":130256261286},{"date":"2021-08-13","current":27.149641,"twenty":31.212428,"median":46.449805,"eighty":51.81997,"marketCap":124250208892},{"date":"2021-08-20","current":25.951827,"twenty":29.568647,"median":46.197194,"eighty":51.793063,"marketCap":118431845636},{"date":"2021-08-27","current":25.551317,"twenty":29.160074,"median":45.882896,"eighty":51.778391,"marketCap":117118021675},{"date":"2021-09-03","current":10.620748,"twenty":28.876855,"median":45.655381,"eighty":51.774136,"marketCap":128003991638},{"date":"2021-09-10","current":10.546903,"twenty":28.583686,"median":45.43354,"eighty":51.737204,"marketCap":127440924226},{"date":"2021-09-17","current":9.908289,"twenty":28.128178,"median":45.28035,"eighty":51.669892,"marketCap":119370291322},{"date":"2021-09-24","current":9.779132,"twenty":27.82689,"median":44.686819,"eighty":51.590126,"marketCap":117868778224},{"date":"2021-09-30","current":10.025874,"twenty":27.27478,"median":44.601887,"eighty":51.56014,"marketCap":121247182695},{"date":"2021-10-08","current":9.186602,"twenty":27.046772,"median":44.130413,"eighty":51.548113,"marketCap":111092433281},{"date":"2021-10-15","current":9.318231,"twenty":26.569923,"median":36.694857,"eighty":51.507128,"marketCap":112761505517},{"date":"2021-10-22","current":9.220183,"twenty":26.170808,"median":35.563772,"eighty":51.434346,"marketCap":112376076242},{"date":"2021-10-29","current":8.887419,"twenty":25.602517,"median":35.364793,"eighty":51.352853,"marketCap":108052495084},{"date":"2021-11-05","current":8.456886,"twenty":10.558373,"median":34.998178,"eighty":51.164241,"marketCap":102987534377},{"date":"2021-11-12","current":8.560231,"twenty":10.416496,"median":34.764786,"eighty":50.984786,"marketCap":104675854613},{"date":"2021-11-19","current":8.91034,"twenty":10.070918,"median":34.408066,"eighty":50.914517,"marketCap":108802859634},{"date":"2021-11-26","current":8.631049,"twenty":9.844574,"median":32.881851,"eighty":50.794169,"marketCap":105426219162},{"date":"2021-12-03","current":8.737756,"twenty":9.729778,"median":31.787963,"eighty":50.680984,"marketCap":106926948261},{"date":"2021-12-10","current":8.646346,"twenty":9.412104,"median":31.673805,"eighty":50.542589,"marketCap":105988992574},{"date":"2021-12-17","current":8.284795,"twenty":9.319774,"median":31.39672,"eighty":50.326681,"marketCap":101486805279},{"date":"2021-12-24","current":8.338086,"twenty":9.192112,"median":31.22719,"eighty":50.196443,"marketCap":102237169828},{"date":"2021-12-31","current":8.333922,"twenty":9.141505,"median":30.384431,"eighty":50.006669,"marketCap":102408380965},{"date":"2022-01-07","current":8.978555,"twenty":8.282213,"median":8.578854,"eighty":8.931855,"marketCap":109910826457},{"date":"2022-01-14","current":9.402408,"twenty":8.355848,"median":8.935267,"eighty":9.27511,"marketCap":115350099439},{"date":"2022-01-21","current":9.274157,"twenty":8.495499,"median":9.134096,"eighty":9.308362,"marketCap":114037171478},{"date":"2022-01-28","current":8.181531,"twenty":8.355848,"median":8.96544,"eighty":9.254892,"marketCap":100345208455},{"date":"2022-02-04","current":8.353845,"twenty":8.333922,"median":8.935267,"eighty":9.242048,"marketCap":102408380965},{"date":"2022-02-11","current":8.398082,"twenty":8.353845,"median":8.585644,"eighty":9.231359,"marketCap":103158625515},{"date":"2022-02-18","current":8.372232,"twenty":8.353845,"median":8.539109,"eighty":9.218737,"marketCap":103346186652},{"date":"2022-02-25","current":7.955221,"twenty":8.320426,"median":8.459805,"eighty":9.215937,"marketCap":98440722082},{"date":"2022-03-04","current":6.997914,"twenty":8.192451,"median":8.399622,"eighty":9.134096,"marketCap":86627835432},{"date":"2022-03-11","current":6.659587,"twenty":7.910139,"median":8.387341,"eighty":9.033931,"marketCap":82315194274},{"date":"2022-03-18","current":7.006091,"twenty":7.259352,"median":8.362252,"eighty":8.978555,"marketCap":86252823158},{"date":"2022-03-25","current":7.371317,"twenty":7.236339,"median":8.351954,"eighty":8.952325,"marketCap":90752970453},{"date":"2022-04-01","current":4.675869,"twenty":7.058972,"median":8.308293,"eighty":8.918209,"marketCap":84106186785},{"date":"2022-04-08","current":4.547747,"twenty":6.942633,"median":8.219605,"eighty":8.830117,"marketCap":81837075137},{"date":"2022-04-14","current":4.387704,"twenty":6.616876,"median":8.186991,"eighty":8.674624,"marketCap":78826492940},{"date":"2022-04-22","current":4.248774,"twenty":6.241316,"median":8.048348,"eighty":8.582928,"marketCap":74903847557},{"date":"2022-04-29","current":4.469038,"twenty":4.692503,"median":7.744517,"eighty":8.568318,"marketCap":77518944479},{"date":"2022-05-06","current":4.081901,"twenty":4.488006,"median":7.565869,"eighty":8.547152,"marketCap":70215607624},{"date":"2022-05-13","current":4.322075,"twenty":4.384485,"median":7.532014,"eighty":8.525703,"marketCap":73016762184},{"date":"2022-05-20","current":4.632904,"twenty":4.384485,"median":7.412742,"eighty":8.466335,"marketCap":79366045852},{"date":"2022-05-27","current":4.680568,"twenty":4.387704,"median":7.259352,"eighty":8.459805,"marketCap":80113020401},{"date":"2022-06-02","current":4.525356,"twenty":4.432565,"median":7.058972,"eighty":8.419371,"marketCap":77872096754},{"date":"2022-06-10","current":4.621539,"twenty":4.4352,"median":7.002002,"eighty":8.402782,"marketCap":78992558577},{"date":"2022-06-17","current":4.735988,"twenty":4.463986,"median":6.662821,"eighty":8.398698,"marketCap":80859994950},{"date":"2022-06-24","current":5.142082,"twenty":4.471352,"median":6.514843,"eighty":8.397313,"marketCap":88142996805},{"date":"2022-06-30","current":5.423776,"twenty":4.472615,"median":6.245656,"eighty":8.391253,"marketCap":92811587738},{"date":"2022-07-08","current":5.73435,"twenty":4.494949,"median":5.753227,"eighty":8.378276,"marketCap":98227153219},{"date":"2022-07-15","current":5.413863,"twenty":4.510715,"median":5.74317,"eighty":8.371172,"marketCap":91877869551},{"date":"2022-07-22","current":5.179385,"twenty":4.519814,"median":5.724312,"eighty":8.360609,"marketCap":87956253168},{"date":"2022-07-29","current":4.986361,"twenty":4.532767,"median":5.592688,"eighty":8.353922,"marketCap":84781611334},{"date":"2022-08-05","current":4.966061,"twenty":4.543731,"median":5.423776,"eighty":8.35271,"marketCap":84221380422},{"date":"2022-08-12","current":4.728381,"twenty":4.557367,"median":5.285894,"eighty":8.341135,"marketCap":80299764039},{"date":"2022-08-19","current":4.642899,"twenty":4.56463,"median":5.258084,"eighty":8.325824,"marketCap":78058840391},{"date":"2022-08-26","current":8.493761,"twenty":4.56647,"median":5.277824,"eighty":8.341135,"marketCap":78058840391},{"date":"2022-09-02","current":8.238862,"twenty":4.578556,"median":5.413863,"eighty":8.355149,"marketCap":75444429469},{"date":"2022-09-09","current":8.208746,"twenty":4.591042,"median":5.480211,"eighty":8.353922,"marketCap":74882486287},{"date":"2022-09-16","current":8.11962,"twenty":4.598745,"median":5.696236,"eighty":8.353089,"marketCap":73385034348},{"date":"2022-09-23","current":7.794047,"twenty":4.606594,"median":5.727415,"eighty":8.344741,"marketCap":69090235901},{"date":"2022-09-30","current":7.678478,"twenty":4.613732,"median":5.752609,"eighty":8.328524,"marketCap":68195810112},{"date":"2022-10-07","current":7.78297,"twenty":4.623812,"median":5.823839,"eighty":8.317285,"marketCap":69119872580},{"date":"2022-10-14","current":8.22397,"twenty":4.634903,"median":6.267354,"eighty":8.303007,"marketCap":72261684970},{"date":"2022-10-21","current":8.894846,"twenty":4.643031,"median":6.606198,"eighty":8.353467,"marketCap":77621247282},{"date":"2022-10-28","current":8.400958,"twenty":4.643734,"median":6.721508,"eighty":8.371879,"marketCap":73185747437},{"date":"2022-11-04","current":8.90828,"twenty":4.646216,"median":7.016023,"eighty":8.396002,"marketCap":78360497256},{"date":"2022-11-11","current":9.100313,"twenty":4.655414,"median":7.236339,"eighty":8.407643,"marketCap":80763059672},{"date":"2022-11-18","current":9.403245,"twenty":4.664392,"median":7.335813,"eighty":8.46442,"marketCap":83165622088},{"date":"2022-11-25","current":8.930799,"twenty":4.668952,"median":7.531332,"eighty":8.525171,"marketCap":78360497256},{"date":"2022-12-02","current":9.296925,"twenty":4.676809,"median":7.555053,"eighty":8.584286,"marketCap":82980809594},{"date":"2022-12-09","current":9.313941,"twenty":4.687945,"median":7.567538,"eighty":8.707566,"marketCap":83904872062},{"date":"2022-12-16","current":9.397407,"twenty":4.719639,"median":7.647562,"eighty":8.81303,"marketCap":84459309543},{"date":"2022-12-23","current":9.086129,"twenty":4.729099,"median":7.698595,"eighty":8.889427,"marketCap":81687122140},{"date":"2022-12-30","current":9.281716,"twenty":4.731254,"median":7.710864,"eighty":8.915011,"marketCap":84459309543},{"date":"2023-01-06","current":9.328055,"twenty":4.734382,"median":7.731498,"eighty":8.96145,"marketCap":85752996997},{"date":"2023-01-13","current":9.843426,"twenty":4.737165,"median":7.764775,"eighty":9.024693,"marketCap":92221434271},{"date":"2023-01-20","current":9.630169,"twenty":4.739933,"median":7.808834,"eighty":9.11954,"marketCap":89449246868},{"date":"2023-01-27","current":9.76745,"twenty":4.741255,"median":7.828,"eighty":9.134096,"marketCap":90742934323},{"date":"2023-02-03","current":9.242159,"twenty":4.749977,"median":7.910139,"eighty":9.14912,"marketCap":86307434478},{"date":"2023-02-10","current":8.939647,"twenty":4.760926,"median":7.994821,"eighty":9.145292,"marketCap":82980809594},{"date":"2023-02-17","current":8.502405,"twenty":4.779418,"median":8.042416,"eighty":9.134096,"marketCap":78175684763},{"date":"2023-02-24","current":8.382439,"twenty":4.784909,"median":8.105078,"eighty":9.13158,"marketCap":76130387334},{"date":"2023-03-03","current":8.590767,"twenty":4.786195,"median":8.138516,"eighty":9.111513,"marketCap":78525547250},{"date":"2023-03-10","current":8.613919,"twenty":8.572182,"median":8.603737,"eighty":8.631438,"marketCap":78156015263},{"date":"2023-03-17","current":8.854074,"twenty":8.686159,"median":14.627146,"eighty":50.137268,"marketCap":81112271159},{"date":"2023-03-24","current":8.653874,"twenty":8.680699,"median":14.555372,"eighty":50.059787,"marketCap":80188441192},{"date":"2023-03-31","current":8.841045,"twenty":8.682095,"median":14.465882,"eighty":50.052946,"marketCap":81297037153},{"date":"2023-04-06","current":26.385992,"twenty":8.683492,"median":14.468662,"eighty":50.046105,"marketCap":76623190314},{"date":"2023-04-14","current":29.091238,"twenty":8.680699,"median":14.463101,"eighty":49.815888,"marketCap":84562460636},{"date":"2023-04-21","current":28.343601,"twenty":8.680699,"median":14.463101,"eighty":49.757313,"marketCap":82346850314},{"date":"2023-04-28","current":27.787899,"twenty":8.680699,"median":14.463101,"eighty":49.691641,"marketCap":80131239992},{"date":"2023-05-05","current":27.186497,"twenty":8.680699,"median":14.463101,"eighty":49.389192,"marketCap":78525547250},{"date":"2023-05-12","current":26.022356,"twenty":8.680699,"median":14.463101,"eighty":49.1783,"marketCap":74645461386},{"date":"2023-05-19","current":25.609528,"twenty":8.680699,"median":14.463101,"eighty":48.945058,"marketCap":72428269463},{"date":"2023-05-25","current":25.452944,"twenty":8.682095,"median":14.465882,"eighty":48.625163,"marketCap":71689205489},{"date":"2023-06-02","current":24.881313,"twenty":8.680699,"median":14.463101,"eighty":48.313875,"marketCap":69841545554},{"date":"2023-06-09","current":25.44461,"twenty":8.680699,"median":14.463101,"eighty":48.13438,"marketCap":71319673502},{"date":"2023-06-16","current":25.567055,"twenty":8.680699,"median":14.463101,"eighty":47.936748,"marketCap":71319673502},{"date":"2023-06-23","current":22.156893,"twenty":8.680699,"median":14.463101,"eighty":47.800493,"marketCap":61469866445},{"date":"2023-06-30","current":22.891344,"twenty":8.680699,"median":14.463101,"eighty":47.612323,"marketCap":62932979993},{"date":"2023-07-07","current":23.003349,"twenty":8.682095,"median":14.465882,"eighty":47.475199,"marketCap":63117534187},{"date":"2023-07-14","current":23.348328,"twenty":8.682095,"median":14.465882,"eighty":47.339122,"marketCap":64963076122},{"date":"2023-07-21","current":23.124147,"twenty":8.682095,"median":14.465882,"eighty":47.120587,"marketCap":64040305154},{"date":"2023-07-28","current":23.882752,"twenty":8.682095,"median":14.465882,"eighty":46.941508,"marketCap":66070401283},{"date":"2023-08-04","current":22.5111,"twenty":8.682095,"median":14.465882,"eighty":46.556098,"marketCap":62379317413},{"date":"2023-08-11","current":21.031429,"twenty":8.682095,"median":14.465882,"eighty":46.490275,"marketCap":57950016768},{"date":"2023-08-18","current":20.109761,"twenty":8.682095,"median":14.465882,"eighty":46.446515,"marketCap":55013725665},{"date":"2023-08-25","current":27.35707,"twenty":8.682095,"median":14.465882,"eighty":46.446515,"marketCap":55381710452},{"date":"2023-09-01","current":26.972418,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54829733271},{"date":"2023-09-08","current":26.744198,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":53725778910},{"date":"2023-09-15","current":26.901969,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54461748484},{"date":"2023-09-22","current":26.83754,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54093763697},{"date":"2023-09-29","current":25.789185,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52069847368},{"date":"2023-10-06","current":25.16334,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":50781900614},{"date":"2023-10-13","current":25.840139,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52069847368},{"date":"2023-10-20","current":24.416834,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":49125969072},{"date":"2023-10-27","current":26.714516,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53725778910},{"date":"2023-11-03","current":30.567338,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":61637451832},{"date":"2023-11-10","current":31.39511,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63293383374},{"date":"2023-11-17","current":34.642006,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":70469086721},{"date":"2023-11-24","current":33.820877,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":69365132360},{"date":"2023-12-01","current":33.323855,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":68629162786},{"date":"2023-12-08","current":30.229794,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":62005436619},{"date":"2023-12-15","current":30.948108,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63845360554},{"date":"2023-12-22","current":28.291375,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":58325588749},{"date":"2023-12-29","current":30.804548,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63845360554},{"date":"2024-01-05","current":29.592871,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":60901482258},{"date":"2024-01-12","current":28.772914,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":59245550716},{"date":"2024-01-19","current":26.217575,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53909771304},{"date":"2024-01-26","current":25.960692,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53173801730},{"date":"2024-02-02","current":25.634057,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52437832156},{"date":"2024-02-09","current":26.045455,"twenty":8.684903,"median":14.482873,"eighty":46.363102,"marketCap":53541786517},{"date":"2024-02-16","current":28.187439,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":57957603961},{"date":"2024-02-23","current":28.246863,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":57773611568},{"date":"2024-03-01","current":27.959549,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":57221634387},{"date":"2024-03-08","current":26.060017,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":53357794123},{"date":"2024-03-15","current":29.321008,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":59981520290},{"date":"2024-03-22","current":27.457347,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":56117680026},{"date":"2024-03-28","current":27.274509,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":55565702846},{"date":"2024-04-05","current":20.502088,"twenty":8.68491,"median":14.545212,"eighty":46.385567,"marketCap":51738890207},{"date":"2024-04-12","current":19.836504,"twenty":8.684917,"median":14.622337,"eighty":46.379948,"marketCap":50087649030},{"date":"2024-04-19","current":17.00797,"twenty":8.684917,"median":14.824165,"eighty":46.379948,"marketCap":42908870597},{"date":"2024-04-26","current":20.158221,"twenty":8.685111,"median":15.006965,"eighty":46.368715,"marketCap":50793833997},{"date":"2024-05-03","current":20.900402,"twenty":8.685111,"median":17.666939,"eighty":46.368715,"marketCap":52627546416},{"date":"2024-05-10","current":22.594528,"twenty":8.68601,"median":19.495478,"eighty":46.368715,"marketCap":57028456221},{"date":"2024-05-17","current":22.482225,"twenty":8.68601,"median":19.836504,"eighty":46.368715,"marketCap":56661713737},{"date":"2024-05-24","current":20.929348,"twenty":8.68601,"median":20.158221,"eighty":46.368715,"marketCap":52627546416},{"date":"2024-05-31","current":20.689517,"twenty":8.68601,"median":20.438856,"eighty":46.368715,"marketCap":52077432691},{"date":"2024-06-07","current":20.788148,"twenty":8.707461,"median":20.694975,"eighty":46.368715,"marketCap":52260803932},{"date":"2024-06-14","current":20.150143,"twenty":8.757175,"median":20.694975,"eighty":46.368715,"marketCap":50610462756},{"date":"2024-06-21","current":19.02184,"twenty":8.763371,"median":20.705001,"eighty":46.368715,"marketCap":47676522886},{"date":"2024-06-28","current":19.542074,"twenty":8.763371,"median":20.705001,"eighty":46.368715,"marketCap":48960121579},{"date":"2024-07-05","current":20.717633,"twenty":8.763371,"median":20.708507,"eighty":46.368715,"marketCap":51894061449},{"date":"2024-07-12","current":21.125844,"twenty":8.763371,"median":20.717171,"eighty":46.368715,"marketCap":52994288900},{"date":"2024-07-19","current":20.833056,"twenty":8.763371,"median":20.76172,"eighty":46.368715,"marketCap":52260803932},{"date":"2024-07-26","current":20.391805,"twenty":8.763371,"median":20.774673,"eighty":46.368715,"marketCap":51343947723},{"date":"2024-08-02","current":20.403694,"twenty":8.763371,"median":20.774673,"eighty":46.368715,"marketCap":51343947723},{"date":"2024-08-09","current":20.920099,"twenty":8.763371,"median":20.788148,"eighty":46.368715,"marketCap":52994288900},{"date":"2024-08-16","current":13.474849,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":59895993625},{"date":"2024-08-23","current":12.806368,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":57165173247},{"date":"2024-08-30","current":13.085579,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":58803665474},{"date":"2024-09-06","current":12.836322,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":57711337322},{"date":"2024-09-13","current":13.073008,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":58621610782},{"date":"2024-09-20","current":13.560082,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":61170376468},{"date":"2024-09-27","current":14.842966,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":67360235991},{"date":"2024-10-04","current":16.724157,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":75552697126},{"date":"2024-10-10","current":15.372928,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":68998728218},{"date":"2024-10-18","current":15.412732,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":68816673526},{"date":"2024-10-25","current":14.435061,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":64447360921},{"date":"2024-11-01","current":14.669834,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":65539689073},{"date":"2024-11-08","current":14.122653,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":62808868695},{"date":"2024-11-15","current":13.694576,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60260103008},{"date":"2024-11-22","current":13.659673,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60078048317},{"date":"2024-11-29","current":13.461736,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":59167774857},{"date":"2024-12-06","current":13.618076,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":59713938933},{"date":"2024-12-13","current":13.728207,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60078048317},{"date":"2024-12-20","current":13.413238,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":58439556090},{"date":"2024-12-27","current":13.507288,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":58803665474},{"date":"2025-01-03","current":12.783861,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":55708735712},{"date":"2025-01-10","current":11.99376,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52067641874},{"date":"2025-01-17","current":12.179201,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52915350334},{"date":"2025-01-24","current":11.936992,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52187991566},{"date":"2025-01-28","current":11.667884,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":51278793107},{"date":"2025-02-07","current":12.358438,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":54006388485},{"date":"2025-02-14","current":13.472496,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":58734220474},{"date":"2025-02-21","current":13.855323,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":60734457084},{"date":"2025-02-28","current":13.401695,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":58552380782},{"date":"2025-03-07","current":13.845547,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":60734457084},{"date":"2025-03-14","current":14.627846,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":64189411230},{"date":"2025-03-21","current":17.171853,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":64449578833},{"date":"2025-03-28","current":17.828023,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":66776924735},{"date":"2025-04-03","current":18.607188,"twenty":8.758254,"median":20.78141,"eighty":46.385567,"marketCap":69557715461},{"date":"2025-04-11","current":17.2596,"twenty":8.758254,"median":20.717402,"eighty":46.357488,"marketCap":64091525617},{"date":"2025-04-17","current":17.642281,"twenty":8.758794,"median":20.705001,"eighty":46.234928,"marketCap":65669735088},{"date":"2025-04-25","current":18.971902,"twenty":8.757715,"median":20.631385,"eighty":45.993268,"marketCap":70679960108},{"date":"2025-05-02","current":19.027519,"twenty":8.758254,"median":20.543459,"eighty":45.790243,"marketCap":71037833324},{"date":"2025-05-09","current":18.60931,"twenty":8.757715,"median":20.427733,"eighty":45.434847,"marketCap":69964213677},{"date":"2025-05-16","current":19.119426,"twenty":8.757715,"median":20.391805,"eighty":44.686655,"marketCap":72469326187},{"date":"2025-05-23","current":19.674285,"twenty":8.757715,"median":20.317327,"eighty":41.07031,"marketCap":74795502089},{"date":"2025-05-30","current":20.853432,"twenty":8.757715,"median":20.194397,"eighty":35.483307,"marketCap":79626790502},{"date":"2025-06-06","current":21.257091,"twenty":8.757715,"median":20.194397,"eighty":34.895645,"marketCap":81375206580},{"date":"2025-06-13","current":25.825329,"twenty":8.757715,"median":20.194397,"eighty":34.568065,"marketCap":98902174152},{"date":"2025-06-20","current":23.349274,"twenty":8.757715,"median":20.194397,"eighty":34.239735,"marketCap":89244457327},{"date":"2025-06-27","current":24.730575,"twenty":8.758254,"median":20.194879,"eighty":33.775233,"marketCap":94788702171},{"date":"2025-07-04","current":26.12919,"twenty":8.758254,"median":20.194879,"eighty":33.366035,"marketCap":100154100407},{"date":"2025-07-11","current":27.696846,"twenty":8.758254,"median":20.194879,"eighty":32.285338,"marketCap":106056038466},{"date":"2025-07-15","current":29.746194,"twenty":8.758254,"median":20.194879,"eighty":32.084404,"marketCap":113925289213}],"updateTime":1752705873258}}}